|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 39/00 | |
| C07K 16/24 |
| (11) | Number of the document | 3075394 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16165736.6 |
| Date of filing the European patent application | 2011-08-23 | |
| (97) | Date of publication of the European application | 2016-10-05 |
| (45) | Date of publication and mention of the grant of the patent | 2018-11-28 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 376097 P | 2010-08-23 | US | |
| 406759 P | 2010-10-26 | US | |
| 411183 P | 2010-11-08 | US | |
| 201161480635 P | 2011-04-29 | US |
| (72) |
Simard, John, US
|
| (73) |
XBiotech, Inc,
1055 West Hastings Street, Suite 300, Vancouver, British Columbia V6E 2E9,
CA
|
| (54) | TREATMENT FOR NEOPLASTIC DISEASES |
| TREATMENT FOR NEOPLASTIC DISEASES |